智通财经APP讯，海普瑞(002399.SZ)公告，公司近日收到波兰卫生监督机构(Chief Pharmaceutical Inspector)颁发的《Certificate of GMP Compliance of a Manufacturer》( 简称“GMP 证书”)，该证书已在欧洲药品管理局(EMA)网站公示，认证产品为依诺肝素钠预灌封注射液。
智通财经APP讯，海普瑞(002399.SZ)公告，公司近日收到波兰卫生监督机构(Chief Pharmaceutical Inspector)颁发的《Certificate of GMP Compliance of a Manufacturer》( 简称“GMP 证书”)，该证书已在欧洲药品管理局(EMA)网站公示，认证产品为依诺肝素钠预灌封注射液。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.